Brain Advance Access originally published online on June 9, 2005
Brain 2005 128(10):2281-2290; doi:10.1093/brain/awh572
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Motor reorganization in asymptomatic carriers of a single mutant Parkin allele: a human model for presymptomatic parkinsonism
1 NeuroImage-Nord, Hamburg-Kiel-Lübeck, Germany, 2 Department of Neurology, University Hospital Hamburg-Eppendorf, Hamburg, Germany, 3 Department of Neurology, University of Lübeck, Lübeck, Germany, 4 Department of Neurology, Christian-Albrechts-University, Kiel, Germany and 5 Department of Neurology, Central Hospital and Department of Medical Genetics, Eurac Research, Bolzano/Bozen, Italy
Correspondence to: Hartwig Siebner, MD, Department of Neurology, Christian-Albrechts University, Schittenhelmstrasse 10, 24105 Kiel, Germany E-mail: h.siebner{at}neurologie.uni-kiel.de
Mutations in the Parkin gene are the most common known single cause of early-onset parkinsonism. It has been shown that asymptomatic carriers with a single mutant allele have latent presynaptic dopaminergic dysfunction in the striatum. Here we used functional MRI to map movement-related neuronal activity during internally selected or externally determined finger movements in 12 asymptomatic carriers of a Parkin mutation and 12 healthy non-carriers. Mean response times were 63 ms shorter during internally selected movements than during externally guided movements (P = 0.003). There were no differences in mean response times between groups (P > 0.2). Compared with externally determined movements, the internal selection of movements led to a stronger activation of rostral motor areas, including the rostral cingulate motor area (rCMA), rostral supplementary motor area, medial and dorsolateral prefrontal cortices. The genotype had a significant impact on movement-related activation patterns. Asymptomatic carriers showed a stronger increase in movement-related activity in the right rCMA and left dorsal premotor cortex, but only if movements relied on internal cues. In addition, synaptic activity in the rCMA had a stronger influence on activity in the basal ganglia in the context of internally selected movements in asymptomatic carriers relative to non-carriers. We infer that this reorganization of striatocortical motor loops reflects a compensatory effort to overcome latent nigrostriatal dysfunction.
Key Words: functional magnetic resonance imaging; motor reorganization; Parkin gene; Parkinson's disease; presymptomatic parkinsonism
Abbreviations: ANOVA = analysis of variance; BOLD = blood oxygen level-dependent; 18F-DOPA = 18F-fluorodopa; MPTP = N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PET = positron emission tomography; PMd = dorsal premotor cortex; PPI = psycho-physiological interaction; rCMA = rostral cingulate motor area; SMA = supplementary motor area; SPMt = statistical parametric t-map; SVC = small volume correction
Received March 19, 2005. Revised May 17, 2005. Accepted May 19, 2005.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Kloppel, B. Draganski, H. R. Siebner, S. J. Tabrizi, C. Weiller, and R. S. J. Frackowiak Functional compensation of motor function in pre-symptomatic Huntington's disease Brain, June 1, 2009; 132(6): 1624 - 1632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Gierthmuhlen, F Lienau, R Maag, J M Hagenah, G Deuschl, E Fritzer, C Klein, R Baron, and C Helmchen Somatosensory processing in a German family with PINK1 mutations: its potential role in Parkinson disease J. Neurol. Neurosurg. Psychiatry, May 1, 2009; 80(5): 571 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zhang Subclinical cortical reorganization: A preclinical imaging marker for recessively inherited PD? Neurology, March 24, 2009; 72(12): 1036 - 1037. [Full Text] [PDF]
|
|
|
|
|
|
B.F.L. van Nuenen, M. M. Weiss, B. R. Bloem, K. Reetz, T. van Eimeren, K. Lohmann, J. Hagenah, P. P. Pramstaller, F. Binkofski, C. Klein, et al. Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype Neurology, March 24, 2009; 72(12): 1041 - 1047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nandhagopal, M. J. McKeown, and A. J. Stoessl Invited Article: Functional imaging in Parkinson disease Neurology, April 15, 2008; 70(16_Part_2): 1478 - 1488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Klein and M. G. Schlossmacher Parkinson disease, 10 years after its genetic revolution: Multiple clues to a complex disorder Neurology, November 27, 2007; 69(22): 2093 - 2104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Binkofski, K. Reetz, C. Gaser, R. Hilker, J. Hagenah, K. Hedrich, T. van Eimeren, A. Thiel, C. Buchel, P. P. Pramstaller, et al. Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia Neurology, August 28, 2007; 69(9): 842 - 850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-K. Sang, H.-Y. Chang, G. M. Lawless, A. Ratnaparkhi, L. Mee, L. C. Ackerson, N. T. Maidment, D. E. Krantz, and G. R. Jackson A Drosophila Model of Mutant Human Parkin-Induced Toxicity Demonstrates Selective Loss of Dopaminergic Neurons and Dependence on Cellular Dopamine J. Neurosci., January 31, 2007; 27(5): 981 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Klein Implications of genetics on the diagnosis and care of patients with Parkinson disease. Arch Neurol, March 1, 2006; 63(3): 328 - 334. [Abstract] [Full Text] [PDF]
|
|